Core Viewpoint - The company Aorite (605116.SH) announced a share reduction plan due to the funding needs of some partners, with a maximum reduction of 2,176,600 shares, accounting for 0.54% of the total share capital [1] Group 1: Shareholding Structure - As of the announcement date, the total number of shares of the company is 406,195,234, with Tian Tai Bo Rong and its concerted parties holding a total of 170,096,400 shares, representing 41.88% of the total share capital [1] - Tian Tai Bo Rong holds 9,907,200 shares, accounting for 2.44% of the total share capital, while Zhejiang Tong Ben holds 153,583,200 shares, representing 37.81% [1] Group 2: Fundraising and Projects - Aorite was listed on the Shanghai Stock Exchange on September 21, 2020, with a total fundraising amount of 34,317.00 million yuan, and a net amount of 28,404.13 million yuan after deducting issuance costs [2] - The funds raised are intended for projects including the technical transformation of production lines for various pharmaceutical products and the construction of a pilot experimental center [2][3] - The total investment for the projects is 46,110.00 million yuan, with specific allocations for each project detailed in the report [3] Group 3: Convertible Bonds - Aorite plans to issue convertible bonds with a total face value of 81,212.00 million yuan, raising approximately 800,471,428.30 yuan after deducting issuance costs [4] - The issuance is conducted by the lead underwriter Guotai Junan Securities Co., Ltd., and the funds have been verified and deposited into the company's fundraising supervision account [4]